Law360, New York (October 08, 2009) -- Proposed legislation to roll back antitrust exemptions for health and medical malpractice insurance issuers received mixed reviews during a U.S. House of Representatives hearing Thursday, as experts cautioned that the bill as written may not do much to cure the industry's real competitive concerns.
Health care and antitrust experts urged members of the House Judiciary Committee's subcommittee on courts and competition policy to consider the unique nature of health and medical malpractice insurance industry...
